Free Trial
→ Here’s how you could profit from Elon’s NVIDIA partnership (From Behind the Markets) (Ad) Free SABS Stock Alerts

SAB Biotherapeutics (SABS) SEC Filings & 10K Form

SAB Biotherapeutics logo
$1.82 -0.13 (-6.67%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.78 -0.05 (-2.47%)
As of 02/21/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent SAB Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
8:00 AM		RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
02/05/2025
4:00 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
6:11 AM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
4:49 PM		Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:00 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/09/2024
7:21 AM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:15 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:30 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
7:00 AM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:30 PM		Giberson Scott (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		Link David Charles (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		HAMILTON CHRISTINE E (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		Lucera Erick (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SKYLER JAY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		Polvino William James (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM		SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Spragens Jeffrey G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:29 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
6:30 AM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:00 PM		SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SKYLER JAY S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
4:15 PM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
8:35 AM		SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:50 PM		Bausch Christoph Lawrence (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:55 PM		SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM		Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:40 PM		Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SABS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored